Hedge Fund - ADAR1 Capital Management
Keros Therapeutics Inc. (KROS)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $383,806 | 0.03% | 18,851 | $17.54 |
| 2 | 2025 - Q3 (2025-09-30) | $85,258,156 | 8.01% | 5,389,264 | $14.77 |
| 3 | 2025 - Q2 (2025-06-30) | $71,946,674 | 11.03% | 5,389,264 | $13.50 |
| 4 | 2025 - Q1 (2025-03-31) | $15,147,038 | 2.81% | 1,486,461 | $11.61 |
| 5 | 2024 - Q4 (2024-12-31) | $367,984 | 0.07% | 23,246 | $51.97 |
| 6 | 2024 - Q3 (2024-09-30) | $25,845,099 | 4.2% | 445,068 | $49.39 |
| 7 | 2024 - Q2 (2024-06-30) | $25,085,461 | 4.73% | 548,916 | $53.73 |
| 8 | 2024 - Q1 (2024-03-31) | $22,391,687 | 5.07% | 338,243 | $59.30 |
| 9 | 2023 - Q4 (2023-12-31) | $27,367,444 | 9.78% | 688,316 | $31.36 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center